method for treating a proliferative disorder and pharmaceutical

• 收藏
• 分享

专利权人:

BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM;GENENTECH, INC.; THE UNIVERSITY OF TEXAS SYSTEM;BOARD OF REGENTS

发明人:

DEEPAK SAMPATH,LINA HAN,MARINA YURIEVNA KONOPLEVA,MARK MERCHANT

申请号：

BR112018008882

公开号：

BR112018008882A2

申请日:

2016.11.03

申请国别(地区):

BR

年份:

2018

代理人:

摘要：

The present invention is directed to a combination therapy involving a selective bcl-2 inhibitor and a mek inhibitor for treating a patient in need of such therapy. The patient who needs combination therapy is suffering from cancer, such as acute myeloid leukemia.a presente invenção é dirigida a uma terapia de combinação envolvendo um inibidor seletivo de bcl-2 e um inibidor de mek para o tratamento de um paciente com necessidade de tal terapia. o paciente que necessita da terapia de combinação está sofrendo de câncer, tal como leucemia mieloide aguda.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/